Clinical development plan: ursodiol.
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D003110:Colonic Neoplasms / Q000517:prevention & control*; D017277:Drug Approval; D005260:Female; D006801:Humans; D008297:Male; D051381:Rats; D012107:Research Design; D014580:Ursodeoxycholic Acid / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity
D016588:Anticarcinogenic Agents; D014580:Ursodeoxycholic Acid